Safeway Inc. (SWY), DaVita HealthCare Partners Inc (DVA), Repros Therapeutics Inc (RPRX): Today’s Three Best Stocks

Finally, in a bit of an odd move, shares of AbbVie added 3.9% despite a competitor, Repros Therapeutics Inc (NASDAQ:RPRX), reporting positive efficacy and safety data for Androxal, its testosterone-replacement therapy. Specifically, Repros Therapeutics Inc (NASDAQ:RPRX)’ Androxal appeared to be superior to AbbVie’s AndroGel in the study, yet shares of both companies moved decisively higher. However, let’s also consider that AbbVie is much, much more than just AndroGel. With a 3.6% yield, and a forward P/E of just 15, AbbVie investors still aren’t paying much for this pharmaceutical star, even after today’s pop.

The article Today’s 3 Best Stocks originally appeared on Fool.com and is written by Sean Williams.

Fool contributor Sean Williams has no material interest in any companies mentioned in this article. You can follow him on CAPS under the screen name TMFUltraLong, track every pick he makes under the screen name TrackUltraLong, and check him out on Twitter, where he goes by the handle @TMFUltraLong. The Motley Fool owns shares of, and recommends Wells Fargo.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.